HCT+F vs. HCT Alone in Critically Ill Medical Septic Shock Patients
Status:
Completed
Trial end date:
2019-09-27
Target enrollment:
Participant gender:
Summary
This study will be conducted as a single-center, prospective, open-label, randomized trial
that will evaluate adult patients admitted with septic shock to the medical critical care
unit (MCC). The objective of the study is to determine if the use of hydrocortisone plus
fludrocortisone is associated with a faster resolution of shock (defined as 24 hours
vasopressor free) when compared to the use of hydrocortisone alone in medical, critically ill
septic shock patients.